TABLE 1.
Clinical characteristics of the family members.
| Id | Normal value of rang | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| I-1 | I-2 | I-3 | I-4 | II-1 | II-2 | II-3 | II-4 | III-1 | ||
| Gender | Male | Female | Male | Female | Female | Male | Female | Male | Female | |
| Age | 69 | 66 | 58 | 52 | 45 | 40 | 34 | 32 | 9 | |
| TC | 169.76 | 213.46 | 155.07 | 200.31 | 212.69 | 258.7 | 134.96 | 97.84 | 638.06 | <200 mg/dl |
| LDL-C | 99 | 129.93 | 96.29 | 123.74 | 124.9 | 163.19 | 71.54 | 50.66 | 527.46 | ≤120 mg/dl |
| HDL-C | 49.88 | 61.49 | 43.7 | 51.43 | 68.83 | 67.29 | 53.75 | 39.06 | 45.63 | 50–60 mg/dl |
| β-Sitosterol | 1.06 | 1.44 | 1.58 | 1.14 | 1.3 | 1.23 | 1.52 | 1.49 | 3.26 | 0.31∼0.80 mg/dl |
| PLT | 275 | 324 | 172 | 298 | 363 | 240 | 250 | 217 | 289 | 85-303 10^9/L |
| PDW | 10.5 | 10.9 | NaN | 15.4 | 11.4 | 12.1 | NaN | NaN | 15.7 | 11∼26.5 fl |
| MPV | 10.2 | 10.3 | NaN | 12 | 10.6 | 10.8 | NaN | NaN | 12.1 | 7.6∼13.2 fl |
| P-LCR | 25 | 26.1 | NaN | 39.2 | 28.5 | 30.1 | NaN | NaN | 41 | 13∼43% |
| PT | 11 (9–13) | 9.4 (9–13) | 10 (9–13) | 10 (9–13) | ||||||
| APTT | 29 (20–40) | 26.8 (20–40) | 28 (20–40) | 27.3 (20–40) | ||||||
| TT | 17.1 (14–24) | 15 (14–24) | 16.7 (14–24) | 15 (14–24) | ||||||
| FIB | 3.1 (2–4) | 3.84 (2–4) | 3.62 (2-4) | 3.6 (2–4) | ||||||
| PTA | 120 (70–150) | 106.8 (70–150) | 117 (70–150) | 116.5 (70–150) | ||||||
| PAgT | 61 (35–75) | 65.7 (35–75) | 63 (35–75) | 64.3 (35–75) | ||||||
Total cholesterol, TC, Low-density lipoprotein cholesterol; LDL-C, High-density lipoprotein cholesterol; HDL-C, Platelet count; PLT, Platelet distribution width; PDW, Mean platelet volume; MPV, Platelet-large cell ratio; P-LCR, prothrombin time; PT, activated partial thromboplastin time; APTT, thrombin time; TT, fibrinogen coagulative time; FIB, prothrombin time activity; PTA, platelet agglutination test, PAgT.